[1] ZHANG X,LIU Y,SHI X,et al.The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer:a meta-analysis[J].Int J Surg,2015,21:84-91.
[2] CHEN L,HAO Y,ZHU L,et al.Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy[J].Onco Targets Ther,2017,10:4007-4016.
[3] OCK C Y,NAM A R,LEE J,et al.Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer[J].Gastric Cancer,2017,20(2):254-262.
[4] COFFELT S B,WELLENSTEIN M D,DE VISSER K E.Neutrophils in cancer:neutral no more[J].Nat Rev Cancer,2016,16(7):431-446.
[5] THANABALASURIAR A,SCOTT B N V,PEISELER M,et al.Neutrophil extracellular traps confine pseudomonas aeruginosa ocular biofilms and restrict brain invasion[J].Cell Host Microbe,2019,25(4):526-536,e4.
[6] DRUMMOND R A,LIONAKIS M S.Measuring in vivo neutrophil trafficking responses during fungal infection using mixed bone marrow chimeras[J].Methods Mol Biol,2021,2260:179-196.
[7] IVERSEN M B,REINERT L S,THOMSEN M K,et al.An innate antiviral pathway acting before interferons at epithelial surfaces[J].Nat Immunol,2016,17(2):150-158.
[8] EL-BENNA J,HURTADO-NEDELEC M,MARZAIOLI V,et al.Priming of the neutrophil respiratory burst:role in host defense and inflammation[J].Immunol Rev,2016,273(1):180-193.
[9] TALUKDAR S,OH D Y,BANDYOPADHYAY G,et al.Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase[J].Nat Med,2012,18(9):1407-1412.
[10] PERDOMO J,LEUNG H H L,AHMADI Z,et al.Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia[J].Nat Commun,2019,10(1):1322-1336.
[11] NIE M,YANG L,BI X,et al.Neutrophil extracellular traps induced by IL8 promote diffuse large B-cell lymphoma progression via the TLR9 signaling[J].Clin Cancer Res,2019,25(6):1867-1879.
[12] LEE W,KO S Y,MOHAMED M S,et al.Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum[J].J Exp Med,2019,216(1):176-194.
[13] WOLACH O,SELLAR R S,MARTINOD K,et al.Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms[J].Sci Transl Med,2018,10(436):eaan8292.
[14] ZHANG Y,HU Y,MA C,et al.Diagnostic,therapeutic predictive,and prognostic value of neutrophil extracellular traps in patients with gastric adenocarcinoma[J].Front Oncol,2020,10:1036-1049.
[15] LI S,CONG X,GAO H,et al.Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells[J].J Exp Clin Cancer Res,2019,38(1):6.
[16] DADAGLIO G,FAYOLLE C,OBERKAMPF M,et al.IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8 T-cell responses[J].Oncoimmunology,2020,9(1):1758606.
[17] 孙环宇.肿瘤相关中性粒细胞调节胃癌发生发展的机制研究[D].银川:宁夏医科大学,2015.
[18] YU W,WANG Y,GUO P.Notch signaling pathway dampens tumor-infiltrating CD8 T cells activity in patients with colorectal carcinoma[J].Biomed Pharmacother,2018,97:535-542.
[19] DETONI K B,OLIVEIRA I V,NASCIMENTO M M G,et al.Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease[J].Int J Clin Pharm,2017,39(1).95-103
[20] YU P,LONG D,LIAO C,et al.Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer[J].Medicine(Baltimore),2018,97(27):e11387.
[21] KWAK Y,KOH J,PARK Y,et al.Differential prognostic impact of CD8 T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer[J].Br J Cancer,2020,122(9):1399-1408.
[22] ZHANG N,CAO M,DUAN Y,et al.Prognostic role of tumor-infiltrating lymphocytes in gastric cancer:a meta-analysis and experimental validation[J].Arch Med Sci,2019,16(5):1092-1103.
[23] MIDDLETON G W,ANNELS N E,PANDHA H S.Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?[J].Cancer Immunol Immunother,2012,61(1):1-7.
[24] UBUKATA H,MOTOHASHI G,TABUCHI T,et al.Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients[J].J Surg Oncol,2010,102(7):742-747.
[25] LIU T,PENG L,YU P,et al.Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer[J].J Clin Immunol,2012,32(6):1332-1339.
[26] WEI X,JIN Y,TIAN Y,et al.Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients[J].Tumour Biol,2016,37(5):6581-6588.
[27] QIAN L,BIAN G-R,ZHOU Y,et al.Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer[J].Cent Eur J Immunol,2015,40(2):263-265.
[28] LIU J,WANG H,YU Q,et al.Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in non small cell lung carcinoma patients[J].Hum Immunol,2016,77(1):84-89.
[29] SHAO Y,LO C M,LING C C,et al.Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway[J].Cancer Lett,2014,355(2):264-272.
[30] SHIMABUKURO V A,SCHLÖßER H A,GRYSCHOK L,et al.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer[J].Oncotarget,2014,5(13):4651-4664.
[31] ANSELL S M,LESOKHIN A M,BORRELLO I,et al.PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma[J].N Engl J Med,2015,372(4):311-319.
[32] OLKHANUD P B,DAMDINSUREN B,BODOGAI M,et al.Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+T cells to T-regulatory cells[J].Cancer Res,2011,71(10):3505-3515.
[33] NOVA-LAMPERTI E,FANELLI G,BECKER P D,et al.IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses[J].Sci Rep,2016,6:20044.
[34] SCHIOPPA T,MOORE R,THOMPSON R G,et al.B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis[J].Proc Natl Acad Sci U S A,2011,108(26):10662-10667.
[35] AMMIRANTE M,LUO J L,GRIVENNIKOV S,et al.B-cell-derived lymphotoxin promotes castration-resistant prostate cancer[J].Nature,2010,464(7286):302-305.
[36] OU Z,WANG Y,LIU L,et al.Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor(AR)/MMPs signals[J].Oncotarget,2015,6(28):26065-26078.
[37] TSILIMIGRAS DI,MORIS D,MEHTA R,et al.The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma:an international multi-institutional analysis[J].HPB(Oxford),2020,22(12):1667-1674.
[38] LI J,SHAO J,ZHANG X,et al.Prognostic value of the pretreatment systemic immune-inflammation index in patients with colorectal cancer[J].Gastroenterol Res Pract,2020,2020:8781674.
[39] GIRALT J,NAVALPOTRO B,HERMOSILLA E,et al.Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy[J].Oncology,2006,71(5-6):312-319.
[40] BROWN K M,DOMIN C,ARANHA G V,et al.Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas[J].Am J Surg,2005,189(3):278-282.
[41] 申辽辽,贺丽.血浆纤维蛋白原、血小板计数检测在胃癌诊断与预后评估中的临床意义[J].陕西医学杂志,2021,50(4):489-491.
[42] 王晓岐,宋煜.胃癌患者凝血及血小板指标与其临床病理特征的相关性分析[J].血栓与止血学,2022,28(3):616-617,620.
[43] SHI H,JIANG Y,CAO H,et al.Nomogram based on systemic immune-inflammation index to predict overall survival in gastric cancer patients[J].Dis Markers,2018,2018:1787424.
[44] 韩帮岭,汪亦民,薛英威.术前全身免疫炎症指数对胃癌患者预后的影响[J].中华普通外科杂志,2019(4):306-309.
[45] WANG K,DIAO F,YE Z,et al.Prognostic value of systemic immune-inflammation index in patients with gastric cancer[J].Chin J Cancer,2017,36(1):75-82.
[46] 张宇,汪亦民,薛英威.全身免疫炎症指数(SII)与胃癌患者临床病理因素及预后的相关性[J].现代肿瘤医学,2021,29(3):441-445.
[47] NEVES FILHO E H C,DE SANT'ANA R O,NUNES L V S C,et al.Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy:a critical review[J].APMIS,2017,125(2):79-84.
[48] BIONDI A,LIROSI MC,D'UGO D,et al.Neo-adjuvant chemo(radio)therapy in gastric cancer:Current status and future perspectives[J].World J Gastrointest Oncol,2015,7(12):389-400.
[49] CHEN L,YAN Y,ZHU L,et al.Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy[J].Cancer Manag Res,2017,9:849-867.
[50] JOMRICH G,PAIREDER M,KRISTO I,et al.High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma[J].Ann Surg,2021,273(3):532-541.
[51] HIRAHARA N,TAJIMA Y,MATSUBARA T,et al.Systemic immune-inflammation index predicts overall survival in patients with gastric cancer:a propensity score-matched analysis[J].J Gastrointest Surg,2021,25(5):1124-1133.
[52] WANG D,HU X,XIAO L,et al.Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC[J].J Gastrointest Surg,2021,25(2):421-427.
[53] CHEN J,ZHAI E,YUAN Y,et al.Systemic immune-inflammation index for predicting prognosis of colorectal cancer[J].World J Gastroenterol,2017,23(34):6261-6272.
[54] INOUE H,KOSUGA T,KUBOTA T,et al.Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer[J].World J Surg Oncol,2021,19(1):173-183. |
